Trials / Terminated
TerminatedNCT04652752
Clinical Investigation to Evaluate the Safety and Efficacy of Dressing CONNETTIVINA HI TECH in the Management of Superficial Cutaneous Lesions
A Prospective, Open, Clinical Trial to Evaluate the Safety and Efficacy of Dressing CONNETTIVINA HI TECH in the Management of Superficial Cutaneous Lesions
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Fidia Farmaceutici s.p.a. · Industry
- Sex
- Female
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is an open, single arm, prospective clinical investigation to evaluate the performance of CONNETTIVINA HI TECH, in terms of safety and efficacy in the management of superficial cutaneous lesions. The study will be conducted in one center, in Italy and will enroll 50 subjects . Subjects will be followed until confirmation of complete wound closure, and for a maximum of 26 days, with a follow up of 4 days after re-epithelization will be confirmed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CONNETTIVINA HI TECH patch | It is a medical device for topical application in the form of a patch with adhesive transparent polyurethane edge and a central pad impregnated with a solution of hyaluronic acid sodium salt, able to create a hydrating environment, such as to favor the natural healing process of tissue repair in case of bruises, abrasions, small cuts, superficial wounds, burns |
Timeline
- Start date
- 2019-10-12
- Primary completion
- 2022-03-31
- Completion
- 2022-12-30
- First posted
- 2020-12-03
- Last updated
- 2023-10-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04652752. Inclusion in this directory is not an endorsement.